Review
Open access
Jul 2026
Research progress on the regulation of mesothelioma driven by deubiquitinating enzyme BAP1.
Clinical and research priorities in elucidating the signaling pathways governed by BAP1, designing targeted therapeutic strategies for BAP1-mutant cancers, and implementing preventive interventions in BAP1 mutation carriers represent urgent clinical and research priorities.
Wan-Ting Xuan, Yao Dong, Sitong Ma et al.
· Clinical and Experimental Me... · 0 citations